Murphy J E, Donald J F, Layes Molla A
J Int Med Res. 1978;6(5):375-80. doi: 10.1177/030006057800600504.
A single-blind between-patient study in general practice was made to examine the acceptability and analgesic efficacy of a combination of fenoprofen (200 mg) and paracetamol (500 mg) given 3 to 4 times daily for a period of 4 to 14 days in the treatment of acute and chronic pain. The combination was compared with dihydrocodeine tartrate (30 mg) in two groups of 75 patients suffering from a wide variety of presenting conditions, including osteo-arthritis, spondylitis, lumbago, sciatica, non-articular rheumatism and trauma. Clinical and patient assessment indicated that the combination was an effective analgesic combination, significantly better in success rate than dihydrocodeine tartrate and with a much lower incidence of side-effects (13% of patients receiving fenoprofen and paracetamol reported side-effects compared to 37% for the dihydrocodeine group). The combination demonstrated particular success in the treatment of non-articular rheumatism.
在普通医疗实践中进行了一项患者间单盲研究,以检验每日3至4次给予布洛芬(200毫克)和对乙酰氨基酚(500毫克),持续4至14天治疗急慢性疼痛时的可接受性和镇痛效果。在两组各75例患有多种病症(包括骨关节炎、脊柱炎、腰痛、坐骨神经痛、非关节性风湿病和创伤)的患者中,将该组合与酒石酸二氢可待因(30毫克)进行比较。临床和患者评估表明,该组合是一种有效的镇痛组合,成功率显著高于酒石酸二氢可待因,且副作用发生率低得多(接受布洛芬和对乙酰氨基酚的患者中有13%报告有副作用,而二氢可待因组为37%)。该组合在治疗非关节性风湿病方面尤为成功。